CHMP recommends EU conditional approval of Roche’s antibody Mosunetuzumab for people with relapsed…
If approved, Mosunetuzumab would be the first CD20xCD3 T-cell engaging bispecific antibody available to treat Follicular Lymphoma…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.